Publications by authors named "Estefania Cruzval-O'Reilly"
Background: Patients with field cancerization will develop numerous superficial non-melanoma skin cancers (NMSCs). Treating patients with field cancerization can be challenging and burdensome due to the numerous non-melanoma skin cancers (NMSCs) they develop and the frequent dermatology visits required for biopsy and treatment.
Objective: The success rate of diagnosing and treating lesions suspicious for NMSCs on the same day is measured, immediately after biopsy.
Article Synopsis
- - The study reviewed patch test results of patients taking the immunosuppressant methotrexate (MTX) at the University of North Carolina Dermatology from 2010 to 2019, aiming to determine its effect on testing outcomes.
- - Among 674 patients, those on MTX had a positivity rate of 46.8%, compared to 53.4% for the control group, with no significant differences in reactions between the two groups.
- - The findings suggest that methotrexate does not adversely affect patch test results, indicating it can be used safely in patients undergoing patch testing.
Background: Merkel cell carcinoma (MCC) is an aggressive neoplasm with high rates of recurrences. Current guidelines recommend wide local excision (WLE) with 1 to 2 cm margins. However, Mohs micrographic surgery (MMS) offers a potential advantage over WLE because of its ability of sparing healthy tissue and assessing 100% of margins.
View Article and Find Full Text PDFRenal cell carcinoma (RCC) is a common genitourinary malignancy of increasing incidence and significant mortality rate. Skin metastases of RCC are considered a rare phenomenon of unfavorable outcomes. We present a 75-year-old male patient who developed a rapidly evolving lesion on his left cheek four years after undergoing a right radical nephrectomy for non-metastatic RCC.
View Article and Find Full Text PDFBasal cell carcinoma is the most common malignancy in the United States. However, metastasis of basal cell carcinoma is exceedingly rare, with incidence estimates of 0.0028-0.
View Article and Find Full Text PDFBasal cell carcinoma (BCC) is the most common malignancy of the skin. It is an epithelial neoplasm with origin in the precursor cells of the interfollicular epidermis. Even though it has low metastatic potential, delay in management may lead to local destruction and morbidity.
View Article and Find Full Text PDF